#218: Lessons Learned from Eight Years of Drug Development Tool/Novel Methodology Qualification
Chair
President and Chief Executive Officer, Critical Path Institute
Martha A. Brumfield, PhD, heads the Arizona-based non-profit in its mission to catalyze the development of new tools to advance medical product innovation and regulatory science. She has 20 years’ experience at Pfizer most recently as senior vice president of worldwide regulatory...
Read More →
Speakers
Director, Office of Translational Sciences, CDER, FDA
ShaAvhrée Buckman-Garner, MD, PhD, FAAP is the Director of the Office of Translational Sciences, Center for Drug Evaluation and Research (CDER), at the FDA. Prior to serving as Director of OTS, Dr. Buckman-Garner served as Deputy Director for OTS and as medical team leader in the...
Read More →
Executive Director, Chair, ICMRA, European Medicines Agency, Netherlands
Ms Cooke was nominated as Executive Director with a renewable five-year mandate by the Agency’s Management Board on 25 June 2020 and is the first woman at the helm of EMA. "I take up the role of Executive Director of EMA amid a public health crisis of unprecedented scale,” said...
Read More →
Tuesday June 28, 2016 10:30am - 11:30am EDT
201B
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
Trk 08: Reg Affairs,
Forum
- Credit Type ACPE, CME, IACET, RN
- Audience Intermediate
- Featured Topics Partnership Strategies, Clinical Trial Transparency-Clinical Trial Disclos, Increasing Research and Development Innovation, Design Thinking, Approval Pathways
- Interest Area Regulatory Affairs, R&D - Strategic Issues, Clinical Safety & Pharmacovigilance
- format json
- Interest Area Regulatory Affairs,R&D / Strategic Issues,Clinical Safety & Pharmacovigilance
- Featured Topics Partnership Strategies,Clinical Trial Transparency/Clinical Trial Disclos,Increasing Research and Development Innovation,Design Thinking,Approval Pathways
- Credit Type ACPE, CME, IACET, RN
- Tags Forum